Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

The actor, who publicly announced his diagnosis earlier this year, spoke on a virtual panel with I Am ALS and writers from the NBC drama: "I have no reason to be in a good spirit at any time, on any ...

Eric Dane is sharing everything about his ALS battle — including the emotional toll that the devastating diagnosis has taken on him. The “Euphoria” actor, 53, gave the latest update on his health ...

Senator John Fetterman takes *** fall walking near his house in Braddock today. *** spokesperson tells us he went to the hospital. Doctors say he had something called an atrial fibrillation flare up ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Denver-based clothing giant ...

Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod. Laura McNew-Isaacs had makeup done in advance of a dinner and drag show at the ...

People in certain states in America appear to be more likely than others to develop devastating neurological diseases, a new study has indicated. Lou Gehrig's disease—also known as amyotrophic lateral ...

Eric Dane plans on having a spot on the call sheet for as long as possible. In the months since the Greys Anatomy Alum shared he had been diagnosed with amyotrophic lateral sclerosis (ALS) in April, ...

VF Corporation (NYSE:VFC) shares are trading higher in the premarket session on Tuesday. The company reported second-quarter adjusted earnings per share of 52 cents, beating the analyst consensus ...

An artificial-intelligence algorithm that discovers its own way to learn achieves state-of-the-art performance, including on some tasks it had never encountered before. Joel Lehman is at Lila Sciences ...